Stockreport

Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely [Seeking Alpha]

Longboard Pharmaceuticals, Inc.  (LBPH) 
PDF The company plans to initiate a Phase 3 study of bexicaserin and hopes to release data from an open-label extension study later this year. Longboard's financials show [Read more]